Liraglutide for weight loss in obese people

The Lancet

Volumn 375, Issue 9714, 2010, Pages 551-

  Hallberg, Pär ^a   Schwan, Sofie ^b   Melhus, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Smittskyddsenheten   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; LIRAGLUTIDE; PLACEBO; TETRAHYDROLIPSTATIN;

CALORIC INTAKE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; HUMAN; INCIDENCE; LETTER; NAUSEA; NAUSEA AND VOMITING; OBESITY; PRIORITY JOURNAL; STOMACH EMPTYING; VOMITING; WEIGHT REDUCTION;

EID: 76249121426     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60225-5     Document Type: Letter

References (1)

1. Astrup A., Rössner S., Van Gaal L., et al., on behalf of the NN8022-1807 Study Group. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374 (2009) 1606-1616